書誌事項
- タイトル別名
-
- Clinical Experience with Sairei-to in the Treatment of Menier's Disease.
この論文をさがす
抄録
We used Sairei-to in an attempt to alleviate vertigo in 14 patients with Meniere's disease. Sairei-to was administered orally in a dose of 9 grams per day, divided into 3 portions. Subjective symptoms (duration and severity of vertigo) and objective findings (standing test, nystagmus, caloric test, audiometry and the frequency of vertigo) were examined before and 6 months after the start of treatment. The glycerol test, electrocochleography and furosemid-VOR test were used to determine the degree of endlymphatic hydrops.<br>Of the 13 patients treated for 6 months, five were rated as markedly improved, four as moderately improved, three as unchanged and one as worse. One patient complained of diarrhea as a side effect. Sairei-to was effective in seven of the ten patients, who had positive tests for endolymphatic hydrops.<br>Sairei-to has diuretic, anti-allergic, sedatve and anti-coagulative effects. It appears to be effective in the treatment of vertigo in some patients with Meniere's disease.
収録刊行物
-
- 耳鼻咽喉科臨床
-
耳鼻咽喉科臨床 87 (5), 719-726, 1994
耳鼻咽喉科臨床学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204258821248
-
- NII論文ID
- 130001813041
-
- ISSN
- 18844545
- 00326313
- http://id.crossref.org/issn/00326313
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可